Advocacy intelligence hub — real-time data for patient organizations
Beijing Biotech — PHASE1
Eli Lilly and Company — PHASE2
Henan Cancer Hospital — PHASE2
Zhejiang Teruisi Pharmaceutical Inc. — PHASE1, PHASE2
M.D. Anderson Cancer Center — PHASE1
Eastern Cooperative Oncology Group — PHASE2
Northside Hospital, Inc. — PHASE2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — PHASE1, PHASE2
National and Kapodistrian University of Athens
European Institute of Oncology — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Chenix
Solvay
Chenix
(chenodiol)Orphan drugstandardSolvay
Bile Acid [EPC]
12.1 Mechanism of Action Endogenous chenodiol (chenodeoxycholic acid) is a primary bile acid, synthesized from cholesterol in the liver. In CTX, the m...
Ying Lu
The Affiliated People's Hospital of Ningbo University
Hope S. Rugo, MD, MD
University of California, San Francisco
📍 SAN FRANCISCO, CA
Arun Rajan, M.D., M.D
National Cancer Institute (NCI)
📍 BETHESDA, MD
Adeline Vanderver, MD
Children's Hospital of Philadelphia
📍 Los Angeles, California
Jingfu Wang, MD
Shandong Cancer Hospital and Institute
Leona Holmberg
Fred Hutch/University of Washington Cancer Consortium
📍 SEATTLE, WA